SomnoMed Limited (ASX:SOM)
Australia
· Delayed Price · Currency is AUD 0.650
-0.025 (-3.70%)
At close: Mar 9, 2026
SomnoMed Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Revenue | 118.5 | 111.49 | 91.65 | 83.62 | 72.58 | 62.71 | Upgrade
|
| Revenue Growth (YoY) | 18.21% | 21.65% | 9.61% | 15.20% | 15.75% | 9.44% | Upgrade
|
| Cost of Revenue | 47.63 | 44.76 | 36.52 | 31.69 | 28.3 | 24.96 | Upgrade
|
| Gross Profit | 70.87 | 66.73 | 55.13 | 51.92 | 44.28 | 37.74 | Upgrade
|
| Selling, General & Admin | 61.31 | 59.35 | 57.61 | 49.37 | 43.28 | 34.52 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 0.2 | Upgrade
|
| Operating Expenses | 69.79 | 67.04 | 63.46 | 55.53 | 48.41 | 38.6 | Upgrade
|
| Operating Income | 1.08 | -0.31 | -8.33 | -3.6 | -4.13 | -0.85 | Upgrade
|
| Interest Expense | -0.49 | -0.4 | -2.14 | -2.63 | -0.38 | -0.47 | Upgrade
|
| Interest & Investment Income | 0.04 | 0.02 | 0.03 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.79 | -0.08 | 0.2 | -0.35 | 0.73 | -0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | -1.03 | -0.46 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -0.16 | -0.76 | -11.27 | -7.05 | -3.78 | -1.39 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.29 | 0.66 | Upgrade
|
| Pretax Income | -0.16 | -0.76 | -11.27 | -7.05 | -3.5 | -0.73 | Upgrade
|
| Income Tax Expense | 2.4 | 2.69 | 0.97 | 0.82 | 0.93 | 0.35 | Upgrade
|
| Earnings From Continuing Operations | -2.56 | -3.46 | -12.24 | -7.87 | -4.43 | -1.08 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -0.13 | -0.01 | -0.11 | Upgrade
|
| Net Income to Company | -2.56 | -3.46 | -12.24 | -8 | -4.44 | -1.19 | Upgrade
|
| Net Income | -2.56 | -3.46 | -12.24 | -8 | -4.44 | -1.19 | Upgrade
|
| Net Income to Common | -2.56 | -3.46 | -12.24 | -8 | -4.44 | -1.19 | Upgrade
|
| Shares Outstanding (Basic) | 216 | 212 | 121 | 79 | 79 | 78 | Upgrade
|
| Shares Outstanding (Diluted) | 216 | 212 | 121 | 79 | 79 | 78 | Upgrade
|
| Shares Change (YoY) | 19.96% | 75.54% | 53.66% | 0.01% | 0.16% | 24.22% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.10 | -0.10 | -0.06 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.10 | -0.10 | -0.06 | -0.02 | Upgrade
|
| Free Cash Flow | 3.71 | 5.36 | -7.42 | -7.02 | 0.85 | 0.55 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.03 | -0.06 | -0.09 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 59.81% | 59.85% | 60.15% | 62.09% | 61.01% | 60.19% | Upgrade
|
| Operating Margin | 0.91% | -0.28% | -9.09% | -4.31% | -5.69% | -1.36% | Upgrade
|
| Profit Margin | -2.16% | -3.10% | -13.36% | -9.57% | -6.11% | -1.90% | Upgrade
|
| Free Cash Flow Margin | 3.13% | 4.81% | -8.10% | -8.39% | 1.17% | 0.88% | Upgrade
|
| EBITDA | 3.68 | 1.58 | -6.5 | -1.98 | -2.7 | 0.63 | Upgrade
|
| EBITDA Margin | 3.10% | 1.42% | -7.09% | -2.37% | -3.72% | 1.00% | Upgrade
|
| D&A For EBITDA | 2.59 | 1.89 | 1.83 | 1.62 | 1.43 | 1.48 | Upgrade
|
| EBIT | 1.08 | -0.31 | -8.33 | -3.6 | -4.13 | -0.85 | Upgrade
|
| EBIT Margin | 0.91% | -0.28% | -9.09% | -4.31% | -5.69% | -1.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.